Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice

Journal of Hepatology

Volumn 56, Issue 4, 2012, Pages 893-899

  Zhu, Qiang ^a,b   Zou, Li ^a   Jagavelu, Kumaravelu ^a   Simonetto, Douglas A ^a   Huebert, Robert C ^a   Jiang, Zhi Dong ^c   Dupont, Herbert L ^c   Shah, Vijay H ^a  

^a MAYO CLINIC   (United States)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Fibronectin; fibrosis; Intestinal decontamination; Lipopolysaccharide; Liver, angiogenesis; Rifaximin; Toll like receptor 4

Indexed keywords

FIBRONECTIN; LIPOPOLYSACCHARIDE; RIFAXIMIN; TOLL LIKE RECEPTOR 4;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INTESTINE FLORA; LIVER FIBROSIS; MOUSE; MOUSE MUTANT; NONHUMAN; PARACRINE SIGNALING; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; STELLATE CELL;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL MOVEMENT; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOTHELIAL CELLS; FIBRONECTINS; HEPATIC STELLATE CELLS; HUMANS; HYPERTENSION, PORTAL; INTESTINES; LIPOPOLYSACCHARIDES; LIVER CIRRHOSIS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR CROSS-TALK; RIFAMYCINS; TOLL-LIKE RECEPTOR 4;

EID: 84858702708     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.11.013     Document Type: Article

References (41)

1. S.M. Riordan, and R. Williams The intestinal flora and bacterial infection in cirrhosis J Hepatol 45 2006 744 757 (Pubitemid 44466668)
2. G. Szabo, and S. Bala Alcoholic liver disease and the gut-liver axis World J Gastroenterol 16 2010 1321 1329
3. S. Balzan, C. de Almeida Quadros, R. de Cleva, B. Zilberstein, and I. Cecconello Bacterial translocation: overview of mechanisms and clinical impact J Gastroenterol Hepatol 22 2007 464 471 (Pubitemid 46435001)
4. S.L. Friedman Mechanisms of hepatic fibrogenesis Gastroenterology 134 2008 1655 1669 (Pubitemid 351615417)
5. J.P. Pradere, J.S. Troeger, D.H. Dapito, A.A. Mencin, and R.F. Schwabe Toll-like receptor 4 and hepatic fibrogenesis Semin Liver Dis 30 2010 232 244
6. E. Sanchez, J. Such, M.T. Chiva, G. Soriano, T. Llovet, and J. Merce Development of an experimental model of induced bacterial peritonitis in cirrhotic rats with or without ascites Am J Gastroenterol 102 2007 1230 1236 (Pubitemid 46802027)
7. J.B. Soares, P. Pimentel-Nunes, R. Roncon-Albuquerque, and A. Leite-Moreira The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases Hepatol Int 4 2010 659 672
8. Y.H. Paik, R.F. Schwabe, R. Bataller, M.P. Russo, C. Jobin, and D.A. Brenner Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells Hepatology 37 2003 1043 1055 (Pubitemid 36538681)
9. J.S. Lee, D. Semela, J. Iredale, and V.H. Shah Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte? Hepatology 45 2007 817 825 (Pubitemid 46450633)
10. D. Thabut, and V. Shah Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? J Hepatol 53 2010 976 980
11. K. Taura, S. De Minicis, E. Seki, E. Hatano, K. Iwaisako, and C.H. Osterreicher Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis Gastroenterology 135 2008 1729 1738
12. K. Jagavelu, C. Routray, U. Shergill, S.P. O'Hara, W. Faubion, and V.H. Shah Endothelial cell toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver Hepatology 52 2010 590 601
13. E. Seki, S. De Minicis, C.H. Osterreicher, J. Kluwe, Y. Osawa, and D.A. Brenner TLR4 enhances TGF-beta signaling and hepatic fibrosis Nat Med 13 2007 1324 1332 (Pubitemid 350073596)
14. D. Thabut, C. Routray, G. Lomberk, U. Shergill, K. Glaser, and R. Huebert Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis Hepatology 54 2011 573 585
15. R.S. Aziz-Seible, and C.A. Casey Fibronectin: functional character and role in alcoholic liver disease World J Gastroenterol 17 2011 2482 2499
16. N.M. Bass, K.D. Mullen, A. Sanyal, F. Poordad, G. Neff, and C.B. Leevy Rifaximin treatment in hepatic encephalopathy N Engl J Med 362 2010 1071 1081
17. D. Semela, A. Das, D.A. Langer, N. Kang, E. Leof, and V.H. Shah Platelet-derived growth factor signaling through ephrin-B2 regulates hepatic vascular structure and function Gastroenterology 135 2008 671 679
18. J.S. Yang, H.J. Kim, Y.H. Ryu, C.H. Yun, D.K. Chung, and S.H. Han Endotoxin contamination in commercially available pokeweed mitogen contributes to the activation of murine macrophages and human dendritic cell maturation Clin Vaccine Immunol 13 2006 309 313
19. A.P. Gee, D. Sumstad, J. Stanson, P. Watson, J. Proctor, and D. Kadidlo A multicenter comparison study between the Endosafe PTS rapid-release testing system and traditional methods for detecting endotoxin in cell-therapy products Cytotherapy 10 2008 427 435 (Pubitemid 351983166)
20. H.L. DuPont, and Z.D. Jiang Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci Clin Microbiol Infect 10 2004 1009 1011
21. W.R. Jarnagin, D.C. Rockey, V.E. Koteliansky, S.S. Wang, and D.M. Bissell Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis J Cell Biol 127 1994 2037 2048
22. S. Cao, U. Yaqoob, A. Das, U. Shergill, K. Jagavelu, and R.C. Huebert Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells J Clin Invest 120 2010 2379 2394
23. A. Albillos, A. de la Hera, M. Gonzalez, J. Moya, J. Calleja, and J. Monserrat Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement Hepatology 37 2003 208 217 (Pubitemid 36042162)
24. Y. Okamura, M. Watari, E.S. Jerud, D.W. Young, S.T. Ishizaka, and J. Rose The extra domain A of fibronectin activates Toll-like receptor 4 J Biol Chem 276 2001 10229 10233
25. S.P. Gondokaryono, H. Ushio, F. Niyonsaba, M. Hara, H. Takenaka, and S.T. Jayawardana The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4 J Leukoc Biol 82 2007 657 665 (Pubitemid 47367158)
26. R. Ghiselli, O. Cirioni, A. Giacometti, F. Mocchegiani, F. Orlando, and C. Bergnach Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide Peptides 27 2006 2592 2599 (Pubitemid 44584401)
27. J.Y. Hong, E.F. Sato, K. Hiramoto, M. Nishikawa, and M. Inoue Mechanism of liver injury during obstructive jaundice: role of nitric oxide, splenic cytokines, and intestinal flora J Clin Biochem Nutr 40 2007 184 193 (Pubitemid 46984211)
28. P. Bellot, J.C. Garcia-Pagan, R. Frances, J.G. Abraldes, M. Navasa, and M. Perez-Mateo Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis Hepatology 52 2010 2044 2052
29. Z.D. Jiang, S. Ke, and H.L. Dupont Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei Int J Antimicrob Agents 35 2010 278 281
30. E.L. Brown, Q. Xue, Z.D. Jiang, Y. Xu, and H.L. Dupont Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles Antimicrob Agents Chemother 54 2010 388 396
31. R.A. Clark, P. DellaPelle, E. Manseau, J.M. Lanigan, H.F. Dvorak, and R.B. Colvin Blood vessel fibronectin increases in conjunction with endothelial cell proliferation and capillary ingrowth during wound healing J Invest Dermatol 79 1982 269 276 (Pubitemid 12005679)
32. R.A. Clark, J.H. Quinn, H.J. Winn, J.M. Lanigan, P. Dellepella, and R.B. Colvin Fibronectin is produced by blood vessels in response to injury J Exp Med 156 1982 646 651 (Pubitemid 12041423)
33. M.K. Magnusson, and D.F. Mosher Fibronectin: structure, assembly, and cardiovascular implications Arterioscler Thromb Vasc Biol 18 1998 1363 1370 (Pubitemid 28421872)
34. P. Sabatelli, P. Bonaldo, G. Lattanzi, P. Braghetta, N. Bergamin, and C. Capanni Collagen VI deficiency affects the organization of fibronectin in the extracellular matrix of cultured fibroblasts Matrix Biol 20 2001 475 486 (Pubitemid 33016384)
35. K. Moriya, E. Bae, K. Honda, K. Sakai, T. Sakaguchi, and I. Tsujimoto A Fibronectin-independent mechanism of collagen fibrillogenesis in adult liver remodeling Gastroenterology 140 2011 1653 1663
36. S. Zhan, C.C. Chan, B. Serdar, and D.C. Rockey Fibronectin stimulates endothelin-1 synthesis in rat hepatic myofibroblasts via a Src/ERK-regulated signaling pathway Gastroenterology 136 2009 2345 2355 e2341-e2344
37. R. Bataller, and D.A. Brenner Liver fibrosis J Clin Invest 115 2005 209 218 (Pubitemid 40385459)
38. Y. Adachi, L.E. Moore, B.U. Bradford, W. Gao, and R.G. Thurman Antibiotics prevent liver injury in rats following long-term exposure to ethanol Gastroenterology 108 1995 218 224
39. M. Hennenberg, J. Trebicka, D. Buecher, J. Heller, and T. Sauerbruch Lack of effect of norfloxacin on hyperdynamic circulation in bile duct-ligated rats despite reduction of endothelial nitric oxide synthase function: result of unchanged vascular Rho-kinase? Liver Int 29 2009 933 941
40. H.L. DuPont Biologic properties and clinical uses of rifaximin Expert Opin Pharmacother 12 2011 293 302
41. J.S. Bajaj, and O. Riggio Drug therapy: rifaximin Hepatology 52 2010 1484 1488